Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP549331.RAFcljuxW0As9FtuJCECFPeKv5wcpUWATw8yTu8IjqQFo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP549331.RAFcljuxW0As9FtuJCECFPeKv5wcpUWATw8yTu8IjqQFo130_assertion type Assertion NP549331.RAFcljuxW0As9FtuJCECFPeKv5wcpUWATw8yTu8IjqQFo130_head.
- NP549331.RAFcljuxW0As9FtuJCECFPeKv5wcpUWATw8yTu8IjqQFo130_assertion description "[To the best of our knowledge, this is the first prospective analysis in which the prognostic impact of a relatively high number of antigenic markers has been simultaneously analyzed in a large series of uniformly treated patients, showing that the expression of several antigens (particularly CD28 and CD117) on bone marrow plasma cells from patients with MM can help to identify patients at high risk of progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP549331.RAFcljuxW0As9FtuJCECFPeKv5wcpUWATw8yTu8IjqQFo130_provenance.
- NP549331.RAFcljuxW0As9FtuJCECFPeKv5wcpUWATw8yTu8IjqQFo130_assertion evidence source_evidence_literature NP549331.RAFcljuxW0As9FtuJCECFPeKv5wcpUWATw8yTu8IjqQFo130_provenance.
- NP549331.RAFcljuxW0As9FtuJCECFPeKv5wcpUWATw8yTu8IjqQFo130_assertion SIO_000772 18443352 NP549331.RAFcljuxW0As9FtuJCECFPeKv5wcpUWATw8yTu8IjqQFo130_provenance.
- NP549331.RAFcljuxW0As9FtuJCECFPeKv5wcpUWATw8yTu8IjqQFo130_assertion wasDerivedFrom befree-20140225 NP549331.RAFcljuxW0As9FtuJCECFPeKv5wcpUWATw8yTu8IjqQFo130_provenance.
- NP549331.RAFcljuxW0As9FtuJCECFPeKv5wcpUWATw8yTu8IjqQFo130_assertion wasGeneratedBy ECO_0000203 NP549331.RAFcljuxW0As9FtuJCECFPeKv5wcpUWATw8yTu8IjqQFo130_provenance.